Viscogliosi Brothers (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the healthcare industry. VB’s mission is to create, build, operate, and finance companies founded on innovations developed by surgeons to address unmet clinical needs and patient treatment challenges.SNNLive spoke to Dr. Anthony Viscogliosi at the 2012 BioInvest Israel Conference in Haifa.
Anthony G. Viscogliosi has twenty-three years of experience as an accomplished founder,entrepreneur, CEO, board member, leading Wall Street analyst, author, and lecturer. He was the first Wall Street orthopedic industry analyst, and he has authored more than 6,000 pages of investment research on orthopedics. In this interview, he talks about what distinguishes VB from other firms. “[It’s important] to create value in a business. So many investors today are focused on getting to an exit as quickly as possible. At Viscogliosi Brothers, we’re focused on developing real, sustainable long-term value by investing in clinical, regulatory, and reimbursement activities other than just intellectual property.”
He also talks about how the Obama Administration is using the Justice Department to lower the cost of healthcare. “A company cannot develop a product and get it cleared for use in one indication, but then have doctors use it in another. And reimbursement is the key component of tying the technology together with the regulatory process so that the pathway from lab table to clinical use is a seamless thread.” To learn more about Viscogliosi Brothers, visit them online at their website. SNNLive welcomes Dr. Anthony G. Viscogliosi of Viscogliosi Brothers.
© 2019 Stock News Now
Supported by Superior Web Solutions